Press Releases from DelveInsight Business Research LLP (4751 total)
Bladder Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Ass …
Bladder Cancer Pipeline constitutes 80+ key companies continuously working towards developing 100+ Bladder Cancer treatment therapies, analyzes DelveInsight.
Bladder Cancer Overview:
Bladder cancer typically begins in the…
Biliary Tract Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeut …
Biliary Tract Cancer Pipeline constitutes 80+ key companies continuously working towards developing 80+ Biliary Tract Cancer treatment therapies, analyzes DelveInsight.
Biliary Tract Cancer Overview:
Biliary tract…
Ovarian Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Ass …
Ovarian Cancer Pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer treatment therapies, analyzes DelveInsight.
Ovarian Cancer Overview:
**Summary and Paraphrase:**
Ovarian cancer is the…
Non-hodgkin's Lymphoma Clinical and Non-Clinical Studies, Key Companies, Therape …
Non-hodgkin's Lymphoma Pipeline constitutes 200+ key companies continuously working towards developing 220+ Non-hodgkin's Lymphoma treatment therapies, analyzes DelveInsight.
Non-hodgkin's Lymphoma Overview:
Non-Hodgkin Lymphoma (NHL) is a cancer…
Motor Neuron Disease Clinical and Non-Clinical Studies, Key Companies, Therapeut …
Motor Neuron Disease Pipeline constitutes 180+ key companies continuously working towards developing 200+ Motor Neuron Disease treatment therapies, analyzes DelveInsight.
Motor Neuron Disease Overview:
Motor neuron diseases…
B-Cell Lymphoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic As …
B-Cell Lymphoma Pipeline constitutes 295+ key companies continuously working towards developing 300+ B-Cell Lymphoma treatment therapies, analyzes DelveInsight.
B-Cell Lymphoma Overview:
B-cell lymphoma is a form of…
Diabetes Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessmen …
Diabetes Pipeline constitutes 200+ key companies continuously working towards developing 200+ Diabetes treatment therapies, analyzes DelveInsight.
Diabetes Overview:
Diabetes is a chronic metabolic condition marked by elevated…
Glioma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, …
Glioma Pipeline constitutes 180+ key companies continuously working towards developing 200+ Glioma treatment therapies, analyzes DelveInsight.
Glioma Overview:
Glioma is a type of tumor that forms in…
Interstitial Lung Disease Clinical and Non-Clinical Studies, Key Companies, Ther …
Interstitial Lung Disease Pipeline constitutes 120+ key companies continuously working towards developing 120+ Interstitial Lung Disease treatment therapies, analyzes DelveInsight.
Interstitial Lung Disease Overview:
Interstitial lung diseases…
Colorectal Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Colorectal Cancer Pipeline constitutes 195+ key companies continuously working towards developing 200+ Colorectal Cancer treatment therapies, analyzes DelveInsight.
Colorectal Cancer Overview:
Colorectal cancer (CRC) is a condition…
Asthma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, …
Asthma Pipeline constitutes 80+ key companies continuously working towards developing 90+ Asthma treatment therapies, analyzes DelveInsight.
Asthma Overview:
Asthma is a chronic condition affecting the airways, marked…
Parkinson's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Parkinson's Disease Pipeline constitutes 130+ key companies continuously working towards developing 150+ Parkinson's Disease treatment therapies, analyzes DelveInsight.
Parkinson's Disease Overview:
Parkinson's disease (PD) is a chronic,…
Pancreatic Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Pancreatic Cancer Pipeline constitutes 290+ key companies continuously working towards developing 300+ Pancreatic Cancer treatment therapies, analyzes DelveInsight.
Pancreatic Cancer Overview:
Pancreatic cancer occurs when malignant cells…
B-cell Non-hodgkin Lymphoma Clinical and Non-Clinical Studies, Key Companies, Th …
B-cell Non-hodgkin Lymphoma Pipeline constitutes 75+ key companies continuously working towards developing 80+ B-cell Non-hodgkin Lymphoma treatment therapies, analyzes DelveInsight.
B-cell Non-hodgkin Lymphoma Overview:
B-cell non-Hodgkin lymphoma…
Glioblastoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asses …
Glioblastoma Pipeline constitutes 180+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analyzes DelveInsight.
Glioblastoma Overview:
Glioblastoma Multiforme (GBM) is the most common type of…
Alzheimer's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Alzheimer's Disease Pipeline constitutes 110+ key companies continuously working towards developing 120+ Alzheimer's Disease treatment therapies, analyzes DelveInsight.
Alzheimer's Disease Overview:
Alzheimer's disease (AD) is a neurodegenerative…
Acute Lymphocytic Leukemia Clinical and Non-Clinical Studies, Key Companies, The …
Acute lymphocytic leukemia companies working in the Acute Lymphocytic Leukemia market are Orca Biosystems, Inc., Jazz Pharmaceuticals, Shenzhen TargetRx, Inc, Cellectis, ADC Therapeutics S.A., Kunming…
Non-small Cell Lung Cancer Clinical and Non-Clinical Studies, Key Companies, The …
NSCLC Companies working in the Non-small Cell Lung Cancer market are GlaxoSmithKline, Novartis, AstraZeneca, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck,…
Amyotrophic Lateral Sclerosis Clinical and Non-Clinical Studies, Key Companies, …
Amyotrophic Lateral Sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Amyotrophic Lateral Sclerosis treatment therapies, analyzes DelveInsight.
Amyotrophic Lateral Sclerosis Overview:
Amyotrophic Lateral Sclerosis…
Krabbe Disease Clinical and Non-Clinical Studies, Key Companies, Therapeutic Ass …
Krabbe Disease Pipeline constitutes 8+ key companies continuously working towards developing 8+ Krabbe Disease treatment therapies, analyzes DelveInsight.
Krabbe Disease Overview:
Krabbe disease encompasses a range of…
Non-alcoholic Steatohepatitis (NASH) Clinical and Non-Clinical Studies, Key Comp …
Non-alcoholic Steatohepatitis (NASH) Pipeline constitutes 80+ key companies continuously working towards developing 80+ Non-alcoholic Steatohepatitis (NASH) treatment therapies, analyzes DelveInsight.
Non-alcoholic Steatohepatitis (NASH) Overview:
Nonalcoholic steatohepatitis (NASH)…
Chronic Inducible Urticaria Clinical and Non-Clinical Studies, Key Companies, Th …
Chronic Inducible Urticaria Pipeline constitutes 4+ key companies continuously working towards developing 4+ Chronic Inducible Urticaria treatment therapies, analyzes DelveInsight.
Chronic Inducible Urticaria Overview:
Chronic Inducible Urticaria…
Hepatitis D Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assess …
Hepatitis D Pipeline constitutes 6+ key companies continuously working towards developing 6+ Hepatitis D treatment therapies, analyzes DelveInsight.
Hepatitis D Overview:
Hepatitis D, or "delta hepatitis," is…
Hepatorenal Syndrome Clinical and Non-Clinical Studies, Key Companies, Therapeut …
Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome treatment therapies, analyzes DelveInsight.
Hepatorenal Syndrome Overview:
Hepatorenal syndrome is a severe complication…
Chronic Rhinosinusitis Without Nasal Polyps Therapeutics Market Size in the 7MM …
DelveInsight's "Chronic Rhinosinusitis Without Nasal Polyps Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the CRSsNP, historical and forecasted…
Cystinosis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessm …
Cystinosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Cystinosis treatment therapies, analyzes DelveInsight.
Cystinosis Overview:
Cystinosis is a rare genetic disorder where the amino…
Aneurysmal Subarachnoid Hemorrhage Clinical and Non-Clinical Studies, Key Compan …
Aneurysmal Subarachnoid Hemorrhage Pipeline constitutes 8+ key companies continuously working towards developing 12+ Aneurysmal Subarachnoid Hemorrhage treatment therapies, analyzes DelveInsight.
Aneurysmal Subarachnoid Hemorrhage Overview:
Aneurysmal subarachnoid hemorrhage…
Alpha-1 Antitrypsin Deficiency Clinical and Non-Clinical Studies, Key Companies, …
Alpha-1 Antitrypsin Deficiency Pipeline constitutes 12+ key companies continuously working towards developing 12+ Alpha-1 Antitrypsin Deficiency treatment therapies, analyzes DelveInsight.
Alpha-1 Antitrypsin Deficiency Overview:
Alpha-1-antitrypsin (AAT) is…
Warm Autoimmune Hemolytic Anemia (wAIHA) Clinical and Non-Clinical Studies, Key …
Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline constitutes 5+ key companies continuously working towards developing 5+ Warm Autoimmune Hemolytic Anemia (wAIHA) treatment therapies, analyzes DelveInsight.
Warm Autoimmune…
Osteosarcoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asses …
Osteosarcoma Pipeline constitutes 25+ key companies continuously working towards developing 30+ Osteosarcoma treatment therapies, analyzes DelveInsight.
Osteosarcoma Overview:
Osteosarcoma, or osteogenic sarcoma, is a rare form of…
Amyotrophic Lateral Sclerosis Therapeutics Market Size in the 7MM is expected to …
DelveInsight's "Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of ALS, historical and forecasted epidemiology as well as the…
Acute Respiratory Distress Syndrome Therapeutics Market Size in the 7MM is expec …
DelveInsight's "Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Acute Respiratory Distress Syndrome (ARDS), historical…
Acute Kidney Injury Therapeutics Market Size in the 7MM is expected to increase …
DelveInsight's "Acute Kidney Injury Market Insights, Epidemiology and Market Forecast-2034" report delivers an in-depth understanding of the Acute Kidney Injury, historical and forecasted epidemiology as…
Night Vision Disturbance Therapeutics Market Size is expected to grow by 2034, e …
DelveInsight's "Night Vision Disturbance Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Night Vision Disturbance (NVD), historical and…
Polymyositis Therapeutics Market Size in the 7MM was ~USD 114 million in 2023, i …
DelveInsight's "Polymyositis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as…
Frontotemporal Dementia Clinical and Non-Clinical Studies, Key Companies, Therap …
Frontotemporal Dementia Pipeline constitutes 15+ key companies continuously working towards developing 20+ Frontotemporal Dementia treatment therapies, analyzes DelveInsight.
Frontotemporal Dementia Overview:
Frontotemporal dementia (FTD) refers to a…
Fragile X Syndrome Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Fragile X Syndrome Pipeline constitutes 10+ key companies continuously working towards developing 12+ Fragile X Syndrome treatment therapies, analyzes DelveInsight.
Fragile X Syndrome Overview:
Fragile X syndrome…
Excessive Daytime Sleepiness Clinical and Non-Clinical Studies, Key Companies, T …
Excessive Daytime Sleepiness Pipeline constitutes 10+ key companies continuously working towards developing 12+ Excessive Daytime Sleepiness treatment therapies, analyzes DelveInsight.
Excessive Daytime Sleepiness Overview:
Excessive daytime sleepiness…
Corneal Endothelial Dystrophy Clinical and Non-Clinical Studies, Key Companies, …
Corneal Endothelial Dystrophy Pipeline constitutes 4+ key companies continuously working towards developing 4+ Corneal Endothelial Dystrophy treatment therapies, analyzes DelveInsight.
Corneal Endothelial Dystrophy Overview:
Corneal Endothelial Dystrophy…
Chronic Pancreatitis Clinical and Non-Clinical Studies, Key Companies, Therapeut …
Chronic Pancreatitis Pipeline constitutes 6+ key companies continuously working towards developing 6+ Chronic Pancreatitis treatment therapies, analyzes DelveInsight.
Chronic Pancreatitis Overview:
Chronic pancreatitis is a long-term inflammatory…
Chronic Kidney Disease Clinical and Non-Clinical Studies, Key Companies, Therape …
Chronic Kidney Disease Pipeline constitutes 80+ key companies continuously working towards developing 85+ Chronic Kidney Disease treatment therapies, analyzes DelveInsight.
Chronic Kidney Disease Overview:
Chronic Kidney Disease…
Narcolepsy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessm …
Narcolepsy Pipeline constitutes 15+ key companies continuously working towards developing 20+ Narcolepsy treatment therapies, analyzes DelveInsight.
Narcolepsy Overview:
Narcolepsy is a rare, long-term brain disorder that causes…
Malignant Pleural Mesothelioma Clinical and Non-Clinical Studies, Key Companies, …
Malignant Pleural Mesothelioma Pipeline constitutes 20+ key companies continuously working towards developing 20+ Malignant Pleural Mesothelioma treatment therapies, analyzes DelveInsight.
Malignant Pleural Mesothelioma Overview:
Malignant pleural mesothelioma…
Von Willebrand Disease Clinical and Non-Clinical Studies, Key Companies, Therape …
Von Willebrand Disease Pipeline constitutes 3 + key companies continuously working towards developing 3+ Von Willebrand Disease treatment therapies, analyzes DelveInsight.
Von Willebrand Disease Overview:
Von Willebrand disease…
HER2+ Gastric Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeut …
HER2+ Gastric Cancer Pipeline constitutes 20+ key companies continuously working towards developing 20+ HER2+ Gastric Cancer treatment therapies, analyzes DelveInsight.
HER2+ Gastric Cancer Overview:
Gastric cancer ranks…
HPV16+ Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asse …
HPV16+ Cancer Pipeline constitutes 10+ key companies continuously working towards developing 12+ HPV16+ Cancer treatment therapies, analyzes DelveInsight.
HPV16+ Cancer Overview:
Human papillomavirus 16 (HPV16) is a…
Osteomyelitis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asse …
Osteomyelitis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Osteomyelitis treatment therapies, analyzes DelveInsight.
Osteomyelitis Overview:
Osteomyelitis is a severe bone infection that can be…
Persistent Epithelial Defects Clinical and Non-Clinical Studies, Key Companies, …
Persistent Epithelial Defects Pipeline constitutes 5+ key companies continuously working towards developing 5+ Persistent Epithelial Defects treatment therapies, analyzes DelveInsight.
Persistent Epithelial Defects Overview:
The cornea is…
Postpartum Depression Clinical and Non-Clinical Studies, Key Companies, Therapeu …
Postpartum Depression Pipeline constitutes 2+ key companies continuously working towards developing 2+ Postpartum Depression treatment therapies, analyzes DelveInsight.
Postpartum Depression Overview:
The arrival of a baby can…
Obesity Therapeutics Market Size in the 7MM is expected to increase by study per …
DelveInsight's "Obesity Market Insights, Epidemiology and Market Forecast-2034" report delivers an in-depth understanding of obesity, historical and forecasted epidemiology as well as the obesity market…
